Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Comisión Nacional de Energía Atómica (CNEA) is the Argentine government agency responsible for nuclear energy research, development, and applications, with a significant focus on the life sciences and healthcare sectors. As a leading producer of radioisotopes in Latin America, CNEA supplies essential materials like Molybdenum-99 and Iodine-131 for diagnostic imaging and radiotherapy. The organization operates several nuclear centers, including the Ezeiza Atomic Center, which houses production facilities and research reactors. CNEA is also a pioneer in Boron Neutron Capture Therapy (BNCT) and maintains strong partnerships with nuclear medicine centers to advance oncological treatments. Its activities span the entire value chain from basic research and isotope production to the development of advanced radiopharmaceuticals. The commission is currently expanding its capabilities through the construction of the RA-10 multipurpose reactor to bolster global supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CNEA.